Search - tctmd.com

Displaying 181 - 200 of 609

Sort: Relevancy | Date

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

Presentation Miami Valves 2024

Edge to Edge repair in Treatment of Tricuspid Regurgitation

Presenter: Thomas Noel

February 01, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Conference News PCR London Valves 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Patient Reported Outcomes in TTVI: Are They Meaningful?

Presenter: David Cohen

October 26, 2023

Presentation TCT 2023

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

Presenter: JoAnn Lindenfeld

October 26, 2023

Presentation TCT 2023

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

Presenter: Rebecca Hahn

October 26, 2023

Presentation TCT 2023

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Presenter: Mahesh Madhavan

October 26, 2023

Presentation TCT 2023

TCT 268: Index of Suspicion: Predictors of Tricuspid Regurgitation progression and Follow-up Echo imaging- An Artificial-intelligence enhanced study

Presenter: Omar Khalique

October 26, 2023

Presentation TCT 2023

TCT 163: Artificial Intelligence-Enabled Assessment of Right Ventricular to Pulmonary Artery Coupling Refines Mortality Prediction in Patients with Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Presenter: Mark Lachmann

October 26, 2023

Presentation TCT 2023

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

Presenter: Federica Gramegna

October 26, 2023

Presentation TCT 2023

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

Presenter: Suzanne Arnold

October 26, 2023

Presentation TCT 2023

TCT 183: Multi-state Modeling of Tricuspid Regurgitation Disease Progression Rate using an EHR-integrated Natural Language Processing Platform

Presenter: Omar Khalique

October 26, 2023

Advertisement

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Edge to Edge repair in Treatment of Tricuspid Regurgitation

Top Structural Heart News of 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Patient Reported Outcomes in TTVI: Are They Meaningful?

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

TCT 268: Index of Suspicion: Predictors of Tricuspid Regurgitation progression and Follow-up Echo imaging- An Artificial-intelligence enhanced study

TCT 163: Artificial Intelligence-Enabled Assessment of Right Ventricular to Pulmonary Artery Coupling Refines Mortality Prediction in Patients with Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

TCT 183: Multi-state Modeling of Tricuspid Regurgitation Disease Progression Rate using an EHR-integrated Natural Language Processing Platform

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content